Doxorubicin liposome Intravenous and Remifentanil Intravenous
Determining the interaction of Doxorubicin liposome Intravenous and Remifentanil Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox, Lipodox 50
Synonyms: Doxorubicin liposomal, DOXOrubicin (Liposomal)
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Doxorubicin liposome Intravenous-Reminyl
- Doxorubicin liposome Intravenous-Reminyl ER
- Doxorubicin liposome Intravenous-Remodulin
- Doxorubicin liposome Intravenous-Remodulin injection
- Doxorubicin liposome Intravenous-Remular-S
- Doxorubicin liposome Intravenous-Renacidin
- Remifentanil Intravenous-Doxy 100
- Remifentanil Intravenous-Doxycycline
- Remifentanil Intravenous-Doxycycline Calcium
- Remifentanil Intravenous-Doxycycline Capsules (Rosacea)
- Remifentanil Intravenous-Doxycycline Capsules with Omega-3 and Vitamin E Capsules
- Remifentanil Intravenous-Doxycycline Delayed Release Capsule